News
EMIS and Citeline partner to expand clinical trial access in the UK
Related Content
We're delighted to announce that EMIS and Citeline Connect have formed a strategic partnership to make clinical trials more accessible to patient populations throughout the UK.
This relationship will allow EMIS to better serve its communities by providing direct, immediate opportunities for eligible patients to participate in clinical trials.
EMIS Recruit will notify clinicians when new opportunities arise for their patients to consider and enroll in clinical trials as a care option. EMIS Recruit uses advanced analytics and algorithms powered by EMIS-X to identify eligible patients.
Citeline Connect is a comprehensive platform and marketplace that powers smarter, simpler patient referrals for clinical trials with HIPAA, GDPR-compliant technology. It enables clinical trial sponsors to securely share recruitment opportunities with a vetted network of patient recruitment companies, healthcare organizations, and patient advocacy groups.
Citeline Connect bridges the gap between Citeline-coordinated clinical trials in search of patients and healthcare organizations with patients looking for promising potential solutions for the management of their conditions.
To read the full press release, please click here.